Live Breaking News & Updates on Covid 19 vaccine production

Stay informed with the latest breaking news from Covid 19 vaccine production on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Covid 19 vaccine production and stay connected to the pulse of your community

Scientific forum discusses impact of COVID-19 vaccine race

Scientific forum discusses impact of COVID-19 vaccine race
english.vov.vn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from english.vov.vn Daily Mail and Mail on Sunday newspapers.

Vietnam , Republic-of , Vietnamese , Le-van-dong , Bui-quang-tuan , Dang-xuan-thanh , Institute-for-preventive-medicine , Vaccine-fund , Vietnam-institute-of-economics , Military-institute , Preventive-medicine , Vietnam-institute

Govt sharply cuts projected availability of COVID-19 vaccine doses by 81 cr for Aug-Dec

Govt sharply cuts projected availability of COVID-19 vaccine doses by 81 cr for Aug-Dec
The Centre has revised the list and cut down the production expectations to 135 crore doses from five COVID-19 vaccines in an affidavit filed before the Supreme Court on June 26
The Centre revised down its May expectation of 216 COVID-19 vaccine production
Joe C Mathew
Updated Jun 27, 2021, 4:26 PM IST
The Central government has brought down the production and availability estimates of COVID-19 vaccine in India during August-December 2021 from 216 crore doses to 135 crore in less than two months' time.
While the government had in a press conference on May 13 said the supply of eight different vaccines that are in various stages of development and production at that time can cumulatively account for 216 crore doses during the August-December period, it has revised the list and cut down the production expectations to 135 crore doses from five COVID-19 vaccines in an affidavit filed before the Supreme Court on June 26.

India , Bharat , Pfizer , Supreme-court-on , Johnson , Serum-institute-of-india , Supreme-court , Serum-institute , Bharat-biotech , Zydus-cadila , Covid-19-vaccine

Adar Poonawalla thanks Biden, Jaishankar for policy change to boost COVID-19 vaccine production

While the firms will continue to make these three vaccines, this action will allow US-based companies that supply these vaccine manufacturers to make their own decisions on which orders to fulfil first

Potus , Jammu-and-kashmir , India , Whitehouse , District-of-columbia , United-states , White-house , Adar-poonawalla , Joe-biden , Astrazeneca , Serum-institute-of-india , Serum-institute

Vaccine production in country not enough: HC

The Delhi High Court on Monday said COVID-19 vaccine production by two companies in India is not enough and the Centre should expedite the process of clearing samples of Panacea Biotec, which has coll

India , Russia , Russian , Justice-manmohan , Justice-navin-chawla , Justice-najmi-waziri , Justice-chawla , Delhi-high-court-on , Russian-direct-investment-fund , High-court , Delhi-high-court , Panacea-biotec

Vaccine takes time for harvesting, quality testing can't be done overnight, says govt

The health ministry said the Centre is regularly interacting with national and international manufacturers like Pfizer, Moderna to make vaccines available in the country

India , Russia , Russian , Bharat , Pfizer , Union-health-ministry , National-expert-group-on-vaccine-administration , Serum-institute , National-expert-group , Vaccine-administration , Bharat-biotech

COVID-19 vaccine: SII, Bharat Biotech to raise production by August

COVID-19 vaccine: SII, Bharat Biotech to raise production by August
While Pune-based Serum Institute said it can ramp up the production to 10 crore, the Hyderabad-based Bharat Biotech said they can raise the production to 7.8 crore doses till August
BusinessToday.In | May 13, 2021 | Updated 09:33 IST
Serum Institute of India and Bharat Biotech have submitted their production plan for the next four months as several states continue to report the shortages of COVID-19 vaccines.
While Pune-based Serum Institute said it can ramp up the production to 10 crore, the Hyderabad-based Bharat Biotech said they can raise the production to 7.8 crore doses till August.
Whole-time Director of Bharat Biotech Dr V Krishna Mohan told the Union Health Ministry and the office of Drugs Controller General of India (DCGI) that the production of Covaxin can be raised to 3.32 crore in July and 7.82 crore in August, which will also be maintained in September.

Uttar-pradesh , India , Karnataka , Delhi , Telangana , Andhra-pradesh , Bharat , V-krishna-mohan , Union-health-ministry , Department-of-pharmaceuticals-rajneesh-tingal , While-serum-institute , Serum-institute-of-india

Covid-19 vaccinations to triple; 14 crore doses to be produced in a month by July

In a submission before the Supreme Court on May 9, the government has said that the Covid-19 vaccine manufacturing capacity of India for three vaccines - Covishield, Covaxin and Sputnik V - could cumulatively cross 14 crore doses a month by July 2021

India , Bharat , Bharat-biotech-intl-ltd , Supreme-court-on , Serum-institute-of-india , Supreme-court , Serum-institute , Biotech-intl-ltd , Central-government , Covid-19-vaccine , Coronavirus-vaccine

Covaxin production to be raised 10x by September, says Harsh Vardhan

Covaxin production to be raised 10x by September, says Harsh Vardhan
Production of Covaxin to rise 10 times in September; Coronavirus vaccine supplies for small states are being replenished in a week, says Harsh Vardhan
BusinessToday.In | April 19, 2021 | Updated 09:49 IST
Union Health Minister Harsh Vardhan
Union health minister Harsh Vardhan said production of Bharat Biotech's COVID-19 vaccine Covaxin will rise 10 times by September. He added that remdesivir manufacturing will be doubled to 74.1 lakh each month by May. He said steps are being taken to increase the basket of vaccines available. Coronavirus vaccine supplies for small states are being replenished in a week, whereas, for big states, it is every four days.

Madhya-pradesh , India , Uttar-pradesh , Chhattisgarh , Kalamboli , Maharashtra , Bharat , Harsh-vardhan , Jamshedpur-rourkela-bokaro , Mehak-agarwal , Express , Union-ministries

Serum Institute, Bharat Biotech to speed up Covid-19 vaccine production

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you.
Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
Track the industry of your choice with a daily newsletter specific to that
industry.
Stay on top of your investments. Track stock prices in your portfolio.
NOTE :
This product is a monthly auto renewal product.
Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
To cancel, communicate from your registered email id and send the mail with the request to assist@bsmail.in. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.

India , Bharat , Visa , Serum-institute-of-india , Serum-institute , Bharat-biotech , Standard-digital , Business-standard , Seamless-sign-up , Business-standard-digital , Debit-cards

Quad nations to announce finance boost to India's COVID-19 vaccine output: US

Quad nations to announce finance boost to India's COVID-19 vaccine output: US
India has urged the other Quad members to invest in its vaccine production capacity in an attempt to counter China's widening vaccine diplomacy
Reuters | March 10, 2021 | Updated 10:26 IST
The aim of the initiative by the Quad, which groups the United States, India, Japan and Australia, would be to reduce manufacturing backlogs, speed vaccination, and defeat some coronavirus mutations
A first ever leaders' meeting of the Quad group of countries on Friday plans to announce financing agreements to support an increase in manufacturing capacity for coronavirus vaccines in India, a senior U.S administration official told Reuters.

China , Australia , Japan , United-states , India , White-house , District-of-columbia , American , Jen-psaki , Joe-biden , Serum-institute , Johnson